[THE9 LIMITED Jun Zhu Chairman and Chief Executive Officer The9 Limited Selects Deloitte as its Independent Registered Public Accounting Firm Shanghai, China September 28, 2009. The9 Limited (NASDAQ: NCTY) (The9 or the Company), an online game operator and developer in China, today announced that the Audit Committee of its Board of Directors has engaged the services of Deloitte Touche]
[Sinovac's H1N1 Vaccine Passes Experts Evaluation Organized by SFDA BEIJING, Aug. 31 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading provider of biopharmaceutical products in China, announced today that Sinovac's H1N1 vaccine has passed the experts evaluation organized by State Food and Drug Administration (SFDA). The vaccine is expected to obtain the production license within this week. On] [FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4]
[September 28, 2009 Mr. Larry Spirgel, Assistant Director, Mail Stop 3720, Division of Corporation Finance, 100 F Street, N.E., Re: China Telecom Corporation Limited Annual Report on Form 20-F for the Fiscal Year ended December 31, 2008 (File No. 001-31517) Dear Mr. Spirgel: Staff SEC Company Form 20-F This is in response to the comment letter from the staff (the]
[Sinovac Wins Beijing Public Health Bureau's Bid to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens BEIJING, Aug. 28 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE: SVA), a leading provider of biopharmaceutical products in China, announced today that the Beijing Public Health Bureau has selected Sinovac as one of the four manufacturers to supply Anflu(R), Sinovac's seasonal influenza vaccine, for the] [FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4]
[September 28, 2009 Mr. Larry Spirgel, Assistant Director, Mail Stop 3720, Division of Corporation Finance, 100 F Street, N.E., Re: China Telecom Corporation Limited Annual Report on Form 20-F for the Fiscal Year ended December 31, 2008 (File No. 001-31517) Dear Mr. Spirgel: Staff SEC Company Form 20-F This is in response to the comment letter from the staff (the]
[Sinovac Wins Beijing Public Health Bureau's Bid to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens BEIJING, Aug. 28 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE: SVA), a leading provider of biopharmaceutical products in China, announced today that the Beijing Public Health Bureau has selected Sinovac as one of the four manufacturers to supply Anflu(R), Sinovac's seasonal influenza vaccine, for the] [FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4]
[THT HEAT TRANSFER TECHNOLOGY, INC. Agreement Company Director THIS AGREEMENT (The BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy and to have the Director perform the duties of an independent director and the Director desires to be so appointed for such position and to perform the duties required of] [2 THT HEAT TRANSFER TECHNOLOGY, INC. Agreement Company Director THIS AGREEMENT (The BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy and to have the Director perform the duties of an independent director and the Director desires to be so appointed for such position and to perform the duties required] [THT HEAT TRANSFER TECHNOLOGY, INC. Agreement Company Director THIS AGREEMENT (The BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy and to have the Director perform the duties of an independent director and the Director desires to be so appointed for such position and to perform the duties required of] [INDEMNIFICATION AGREEMENT Agreement Company Indemnitee This Indemnification Agreement (this RECITALS A. The Company and the Indemnitee recognize that the present state of the law is too uncertain to provide the Companys officers and directors with adequate and reliable advance knowledge or guidance with respect to the legal risks and potential liabilities to which they may become personally exposed as] [INDEMNIFICATION AGREEMENT Agreement Company Indemnitee This Indemnification Agreement (this RECITALS A. The Company and the Indemnitee recognize that the present state of the law is too uncertain to provide the Companys officers and directors with adequate and reliable advance knowledge or guidance with respect to the legal risks and potential liabilities to which they may become personally exposed as] [INDEMNIFICATION AGREEMENT Agreement Company Indemnitee This Indemnification Agreement (this RECITALS A. The Company and the Indemnitee recognize that the present state of the law is too uncertain to provide the Companys officers and directors with adequate and reliable advance knowledge or guidance with respect to the legal risks and potential liabilities to which they may become personally exposed as] [BTHC VIII, INC. I. Objectives Company BTHC VIII, Inc. and its subsidiaries (together, the Code Covered Persons This Code of Ethics ( honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships; Commission compliance with applicable governmental laws, rules and regulations; the prompt internal reporting to an appropriate person] [BTHC VIII, INC. AUDIT COMMITTEE CHARTER The Purpose of the Audit Committee The Audit Committee members are not professional accountants or auditors and their functions are not intended to duplicate or to certify the activities of management and the independent auditor. Consequently, it is not the duty of the Audit Committee to conduct audits or to determine that the Companys] [BTHC VIII, INC. The Purpose of the Compensation Committee The purpose of the Compensation Committee of BTHC VIII, Inc. (the Company) is to discharge the responsibilities of the Companys Board of Directors relating to compensation of the Companys executives, to produce an annual report on executive compensation for inclusion in the Companys proxy statement, and to oversee and advise the] [BTHC VIII, INC. The Purpose of the Governance and Nominating Committee The purpose of the Governance and Nominating Committee of BTHC VIII, Inc. (the "Company"), is to determine the slate of director nominees for election to the Companys Board of Directors, to identify and recommend candidates to fill vacancies occurring between annual stockholder meetings, to review, evaluate and recommend changes] [FORM 8-K CURRENT REPORT September 28, 2009 (September 25, 2009) Date of report (Date of earliest event reported): BTHC VIII, INC. Delaware 000-52232 20-5463509 (State or other jurisdiction of (IRS Employer Identification No.) incorporation or organization) THT Industrial Park, No.5 Nanhuan Road, Tiexi District Siping, Jilin Province 136000 Peoples Republic of China 86-434-3265241 N/A (Former name or former address, if]
[THT HEAT TRANSFER TECHNOLOGY, INC. Agreement Company Director THIS AGREEMENT (The BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy and to have the Director perform the duties of an independent director and the Director desires to be so appointed for such position and to perform the duties required of] [2 THT HEAT TRANSFER TECHNOLOGY, INC. Agreement Company Director THIS AGREEMENT (The BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy and to have the Director perform the duties of an independent director and the Director desires to be so appointed for such position and to perform the duties required] [THT HEAT TRANSFER TECHNOLOGY, INC. Agreement Company Director THIS AGREEMENT (The BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy and to have the Director perform the duties of an independent director and the Director desires to be so appointed for such position and to perform the duties required of] [INDEMNIFICATION AGREEMENT Agreement Company Indemnitee This Indemnification Agreement (this RECITALS A. The Company and the Indemnitee recognize that the present state of the law is too uncertain to provide the Companys officers and directors with adequate and reliable advance knowledge or guidance with respect to the legal risks and potential liabilities to which they may become personally exposed as] [INDEMNIFICATION AGREEMENT Agreement Company Indemnitee This Indemnification Agreement (this RECITALS A. The Company and the Indemnitee recognize that the present state of the law is too uncertain to provide the Companys officers and directors with adequate and reliable advance knowledge or guidance with respect to the legal risks and potential liabilities to which they may become personally exposed as] [INDEMNIFICATION AGREEMENT Agreement Company Indemnitee This Indemnification Agreement (this RECITALS A. The Company and the Indemnitee recognize that the present state of the law is too uncertain to provide the Companys officers and directors with adequate and reliable advance knowledge or guidance with respect to the legal risks and potential liabilities to which they may become personally exposed as] [BTHC VIII, INC. I. Objectives Company BTHC VIII, Inc. and its subsidiaries (together, the Code Covered Persons This Code of Ethics ( honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships; Commission compliance with applicable governmental laws, rules and regulations; the prompt internal reporting to an appropriate person] [BTHC VIII, INC. AUDIT COMMITTEE CHARTER The Purpose of the Audit Committee The Audit Committee members are not professional accountants or auditors and their functions are not intended to duplicate or to certify the activities of management and the independent auditor. Consequently, it is not the duty of the Audit Committee to conduct audits or to determine that the Companys] [BTHC VIII, INC. The Purpose of the Compensation Committee The purpose of the Compensation Committee of BTHC VIII, Inc. (the Company) is to discharge the responsibilities of the Companys Board of Directors relating to compensation of the Companys executives, to produce an annual report on executive compensation for inclusion in the Companys proxy statement, and to oversee and advise the] [BTHC VIII, INC. The Purpose of the Governance and Nominating Committee The purpose of the Governance and Nominating Committee of BTHC VIII, Inc. (the "Company"), is to determine the slate of director nominees for election to the Companys Board of Directors, to identify and recommend candidates to fill vacancies occurring between annual stockholder meetings, to review, evaluate and recommend changes] [FORM 8-K CURRENT REPORT September 28, 2009 (September 25, 2009) Date of report (Date of earliest event reported): BTHC VIII, INC. Delaware 000-52232 20-5463509 (State or other jurisdiction of (IRS Employer Identification No.) incorporation or organization) THT Industrial Park, No.5 Nanhuan Road, Tiexi District Siping, Jilin Province 136000 Peoples Republic of China 86-434-3265241 N/A (Former name or former address, if]
[FORM 8-K CURRENT REPORT August 28, 2009 China Pharmas, ------------------------------ Delaware (State or other jurisdiction oforporation) 000-29532 73-1564807 (IRS Employer Identification Number) 2nd Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 86-898-66811730fe Harbor Statement under the Private Securities Litigation Reform Act of 1995 ITEM 8.01 Other Events]
[Sinovac to Present at 2009 UBS Global Life Sciences Conference BEIJING, Sept. 16 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE: SVA), a leading provider of biopharmaceutical products in China, announced today that Mr. Weidong Yin, Chairman, President & CEO, will present at the 2009 UBS Global Life Sciences Conference in New York City. The presentation is scheduled for Tuesday, September 22,] [FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4]
